Abstract
Introduction/BackgroundHigh-dose progestins have been the mainstay of conservative treatment of atypical endometrial hyperplasia (AEH) and early EC since Bokhman’s first publication in 1985 until today. One of the treatment options...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have